Ginkgo Bioworks (NYSE: DNA) reported Q2 EPS of ($0.92), $0.13 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $20 million versus the consensus estimate of $29.9 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.